Model
Edge
Lyell Immunopharma Inc.
0001866154
Filing Type
4
Filing Date
2/10/2026
Updated
2/11/26, 7:05 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership